Bloodletter of Aclazotz (Borderless)
MARKET NOTE — BLOODLETTER OF ACLAZOTZ (BORDERLESS)
Updated 2026-05-06
Bloodletter of Aclazotz borderless foil is grinding higher on steady accumulation. The 30-day read of +7.1% reveals consistent upward pressure, while the 7-day tick of +0.8% suggests the move is cooling but not reversing. From the $36.45 trough, this spec has climbed +8.6%, placing current price at $39.59 just +0.9% below the recent $39.24 peak, which signals buyers are willing to defend these levels rather than panic into a correction. The mythic status in a recent set provides natural chase demand, and the borderless foil premium remains a liquidity anchor for exits. The data implies a buyers-in-control thesis where dips get bought rather than sold into. Watch whether the next 7-10 days hold above $38.50 or if profit-taking breaks the momentum; a breach below trough would suggest the spec was just early, not right.
Should I Grade This Card?
Get estimated graded values (PSA 9, PSA 10, BGS 9.5) and ROI projections.
Coming SoonSlab Exchange
Compare graded card prices across PSA, BGS, and CGC. Track slab premium trends.
Coming Soon